Feature

Gene Test Guides Eczema Care

Skin scraping assay may help labs support targeted systemic treatment in atopic dermatitis

  • By

  • March 2, 2026

  • 3 min

Share

A 487-gene expression profile test revealed that patients with atopic dermatitis could be categorized into responders to Janus kinase (JAK) inhibitors or Th2-targeted biologics. Conducted as a prospective, multicenter study, researchers utilized noninvasive skin scrapings to validate this test, which aims to enhance the efficacy of systemic therapy selection for moderate-to-severe atopic dermatitis. The test facilitates precision medicine by enabling clinicians to tailor treatments based on individual molecular profiles, potentially leading to improved outcomes in disease management.

Original Source(s)

Gene Test Guides Eczema Care

Skin scraping assay may help labs support targeted systemic treatment in atopic dermatitis

  • March 2, 2026

  • 3 min

Related Content

First Death From Alaskapox Reported

Alaska health officials warned of the risk of Alaskapox in the wake of the first death from the disease in January 2024.

Higher H. pylori Prevalence Seen in Severe Psoriasis

Psoriasis patients show higher Helicobacter pylori infection rates, with potential implications for further research into disease associations.

Physician Turnover After Private Equity Exits

Researchers found physicians in private equity-exiting practices were less likely to stay and more likely to join larger groups within 2 years.